DSpace at EWHA: Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial

View : 875 Download: 0

Full metadata record

DC Field	Value	Language
dc.contributor.author	장중현	*
dc.date.accessioned	2016-08-28T11:08:55Z	-
dc.date.available	2016-08-28T11:08:55Z	-
dc.date.issued	2015	*
dc.identifier.issn	1073-449X	*
dc.identifier.issn	1535-4970	*
dc.identifier.other	OAK-18913	*
dc.identifier.uri	https://dspace.ewha.ac.kr/handle/2015.oak/218330	-
dc.language	English	*
dc.publisher	AMER THORACIC SOC	*
dc.title	Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial	*
dc.type	Meeting Abstract	*
dc.relation.volume	191	*
dc.relation.index	SCIE	*
dc.relation.index	SCOPUS	*
dc.relation.journaltitle	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE	*
dc.identifier.wosid	WOS:000377582803061	*
dc.author.google	Kim, H.	*
dc.author.google	Lee, Y.	*
dc.author.google	Oh, Y. -M.	*
dc.author.google	Rhee, C. K.	*
dc.author.google	Kyung, S.	*
dc.author.google	Chang, J.	*
dc.author.google	Lee, W. -Y.	*
dc.author.google	Kim, J. S.	*
dc.contributor.scopusid	장중현(57193227620)	*
dc.date.modifydate	20240415132519	*